{
    "clinical_study": {
        "@rank": "100809", 
        "arm_group": [
            {
                "arm_group_label": "Tubal Sterilization with bipolar", 
                "arm_group_type": "Active Comparator", 
                "description": "Salpingectomy vs Tubal Sterilisation"
            }, 
            {
                "arm_group_label": "Bilateral Salpingectomy", 
                "arm_group_type": "Active Comparator", 
                "description": "Salpingectomy vs Tubal Sterilisation"
            }
        ], 
        "brief_summary": {
            "textblock": "Randomised study to investigate if salpingectomies done to women wishing tubal sterilisation\n      has an effect on ovarian reserve."
        }, 
        "brief_title": "Salpingectomy vs Tubal Sterilisation in Low Risk for Ovarian Cancer Women and Its Effect on Ovarian Reserve", 
        "condition": "Ovarian Cancer", 
        "condition_browse": {
            "mesh_term": "Ovarian Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Women seeking for tubal sterilisation\n\n        Exclusion Criteria:\n\n          -  women older than 45\n\n          -  family history of ovarian cancer\n\n          -  presence of menopausal symptoms\n\n          -  irregular cycles\n\n          -  Hormone Replacement Therapy or hormone contraceptions the last 3 months\n\n          -  history of previous ovarian or uterine surgeries\n\n          -  imaging suggesting an ovarian cyst or other adnexal pathology during investigation\n\n          -  previous salpingectomy"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "25 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01888159", 
            "org_study_id": "SEvsTSinAMH"
        }, 
        "intervention": [
            {
                "arm_group_label": "Bilateral Salpingectomy", 
                "intervention_name": "Bilateral Salpingectomy", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Tubal Sterilization with bipolar", 
                "intervention_name": "Tubal sterilization with bipolar energy", 
                "intervention_type": "Procedure"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Disinfectants"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "June 25, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Karlstad", 
                    "country": "Sweden", 
                    "state": "V\u00e4rmaland", 
                    "zip": "65185"
                }, 
                "name": "Department of Obstetrics and Gynecology"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "2", 
        "other_outcome": [
            {
                "measure": "Follicle Stimulation Hormone (FSH)", 
                "safety_issue": "Yes", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "Follicle Stimulation Hormone (FSH)", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }
        ], 
        "overall_contact": {
            "email": "lemagarakis@gmail.com", 
            "last_name": "Leonidas Magarakis, MD", 
            "phone": "046737529929"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Sweden: Regional Ethical Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Anti-Mullerian hormone (AMH)and Follicle Stimulation Hormone (FSH)", 
            "safety_issue": "Yes", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01888159"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Karlstad Central Hospital", 
            "investigator_full_name": "Leonidas Magarakis", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Anti-Mullerian hormone (AMH)", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Operative time", 
                "safety_issue": "Yes", 
                "time_frame": "Postoperatively"
            }, 
            {
                "measure": "Complications", 
                "safety_issue": "Yes", 
                "time_frame": "3 months"
            }
        ], 
        "source": "Karlstad Central Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Karlstad Central Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}